Cme (CME) Research & Development (2009 - 2026)

Cme (CME) has reported Research & Development for 18 consecutive years, with $83.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 17.49% year-over-year to $83.3 million in Q2 2026; TTM through Jun 2026 was $306.5 million, a 13.98% increase from a year earlier, with the FY2025 full-year figure at $283.2 million, up 10.71% from the prior year.
• Research & Development was $83.3 million for Q2 2026 at Cme, up from $76.6 million in the prior quarter.
• Over five years, Research & Development peaked at $83.3 million in Q2 2026 and troughed at $45.9 million in Q1 2022.
• A 5-year average of $61.5 million and a median of $61.8 million in 2024 frame the typical range for Research & Development.
• Across the five-year window, Research & Development decreased 6.9% in 2022 and climbed 20.26% in 2024, its largest moves.
• Over 5 years, Research & Development stood at $50.0 million in 2022, then rose by 17.0% to $58.5 million in 2023, then climbed by 12.31% to $65.7 million in 2024, then advanced by 14.46% to $75.2 million in 2025, then climbed by 10.77% to $83.3 million in 2026.
• The last three Research & Development figures came in at $83.3 million (Q2 2026), $76.6 million (Q1 2026), and $75.2 million (Q4 2025), per Business Quant data.